We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Winners Announced of the 14th MEDICA Start-up Competition

By HospiMedica International staff writers
Posted on 20 Nov 2025

At the MEDICA 2025 edition of the MEDICA INNOVATION FORUM, the 14th MEDICA Start-up Competition announced this year’s winners, with SVAN Technologies GmbH taking both 1st place and the Public Vote, followed by AcroCyte Therapeutics in 2nd place and Virtuosis AI in 3rd place. More...

Below is a closer look at the technologies driving these standout young companies and the potential impact they bring to healthcare.

SVAN Technologies GmbH (Vienna, Austria) was awarded the first place prize with its deep-tech innovation for neonatal emergency vascular access. The company is developing an autonomous bone-drilling device designed to provide safe, fast, and precise intraosseous access in premature and full-term newborns. The device automatically detects bone-marrow entry, features a safety-stop mechanism, and offers precise wrist control to minimize injury during urgent, life-saving procedures. Because securing fast intraosseous access for medication and fluid delivery can be challenging in neonatal emergencies, this patented technology could greatly enhance outcomes for newborns and raise the standard of care globally.

AcroCyte Therapeutics (Taipei, Taiwan) secured second place with its precision-medicine and cell-therapy technology. Its core innovation, R³CE (Rapid, Reproducible, Rare Cell Expansion), enables the culture of three-dimensional tissues from a single cell and supports the creation of ex-vivo 3D models from rare cells, stem cells, or circulating tumor cells. This powerful platform for 3D cell culture can support breakthroughs in cancer research, clinical treatment development, and drug discovery.

Virtuosis AI (Lausanne, Switzerland) took third place with its AI-driven voice-analysis platform. By analyzing tone, pitch, cadence, and other acoustic features, the system can detect early indicators of stress, anxiety, and communication difficulties The platform integrates with Microsoft Teams to deliver confidential voice-analysis data and actionable results.

This year’s competition once again demonstrated MEDICA’s role as a global showcase for emerging healthcare technologies. Beyond the top three, the 15 selected finalists represented a broad spectrum of the global medtech innovation landscape, spanning categories such as AI in Healthcare, Health Apps, Lab Diagnostics, and Robotics. The MEDICA Start-up Competition continues to act as a catalyst for identifying promising young companies poised to shape the next generation of medical technology.

Related Links:
SVAN Technologies GmbH
AcroCyte Therapeutics
Virtuosis AI


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.